石墨烯在乳腺癌中应用的全球研究趋势:一个文献计量分析
Mengdi Zhang1, Dongqing Pu2, Minmin Yu3
1First clinical medical college, Shandong University of Traditional Chinese Medicine, jinan, China.
International journal of surgery (London, England)
|June 25, 2025
概括
石墨烯由于其生物相容性和向能力,对乳腺癌 (BC) 治疗有希望. 本文献分析揭示了BC地区对石墨烯应用的研究越来越多,特别是在光热疗法和生物传感中.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 乳腺癌 (BC) 是女性的主要恶性瘤,发病率不断上升.
- 现有的BC诊断和治疗方法存在局限性.
- 由于其生物相容性,生物安全性和向能力,石墨烯为创新的BC治疗提供了潜在的潜力.
研究的目的:
- 在乳腺癌研究中对石墨烯应用进行文献计量分析.
- 为了确定目前的研究状态,趋势,和未来的方向在BC. 石墨烯.
主要方法:
- 从科学网获取的2010-2024年间的1,395篇出版物的图书统计分析.
- 使用CiteSpace和VOSviewer进行数据分析和可视化.
- 根据石墨烯和BC的纳入标准选出版物.
主要成果:
- 从2010年到2024年,关于BC的石墨烯的出版物显著增加.
- 中国在研究成果,引用和H指数方面处于领先地位.
- 关键的研究热点包括光热疗法和生物传感用于BC检测和治疗.
结论:
- 石墨烯在促进乳腺癌诊断和治疗方面具有重大前景.
- 未来的研究应该集中在光热疗法和生物传感应用上.
- 这一分析提供了关于石墨烯在BC研发中的作用的见解.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


